Abstract
Background:
We observe changes of the main lymphocyte subsets (CD16+CD56、CD19、CD3、CD4、and CD8) in COVID-19-infected patients and explore whether the changes are associated with disease severity.
Methods:
One-hundred and fifty-four cases of COVID-19-infected patients were selected and divided into 3 groups (moderate group, severe group and critical group). The flow cytometry assay was performed to examine the numbers of lymphocyte subsets.
Results:
CD3+, CD4+ and CD8 + T lymphocyte subsets were decreased in COVID-19-infected patients. Compared with the moderate group and the sever group, CD3+, CD4+ and CD8+ T cells in the critical group decreased greatly (P < 0.001, P = 0.005 or P = 0.001).
Conclusions:
Reduced CD3+, CD4+, CD8+ T lymphocyte counts may reflect the severity of the COVID-19. Monitoring T cell changes has important implications for the diagnosis and treatment of severe patients who may become critically ill.
Keywords:
CD3(+) T cells; CD4(+) T cells; CD8(+) T cells; COVID-19; Lymphocyte subsets.
Copyright © 2020 Elsevier B.V. All rights reserved.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Betacoronavirus / pathogenicity*
-
Biomarkers / analysis
-
CD3 Complex / genetics
-
CD3 Complex / immunology
-
CD4 Antigens / genetics
-
CD4 Antigens / immunology
-
CD8 Antigens / genetics
-
CD8 Antigens / immunology
-
COVID-19
-
Cardiovascular Diseases / diagnosis*
-
Cardiovascular Diseases / immunology
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / physiopathology
-
Cohort Studies
-
Comorbidity
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / immunology
-
Coronavirus Infections / mortality
-
Coronavirus Infections / physiopathology
-
Diabetes Mellitus / diagnosis*
-
Diabetes Mellitus / immunology
-
Diabetes Mellitus / mortality
-
Diabetes Mellitus / physiopathology
-
Female
-
Gene Expression
-
Humans
-
Immunophenotyping
-
Lung Diseases / diagnosis*
-
Lung Diseases / immunology
-
Lung Diseases / mortality
-
Lung Diseases / physiopathology
-
Male
-
Middle Aged
-
Pandemics
-
Patient Selection
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / physiopathology
-
Prognosis
-
SARS-CoV-2
-
Severity of Illness Index
-
Survival Analysis
-
T-Lymphocyte Subsets / immunology
-
T-Lymphocyte Subsets / pathology*
-
T-Lymphocyte Subsets / virology
Substances
-
Biomarkers
-
CD3 Complex
-
CD4 Antigens
-
CD8 Antigens